Scansource (SCSC) Director Reports 3,693-Share Acquisition on Form 4

Rhea-AI Filing Summary

SCANSOURCE, INC. (SCSC) director Jeffrey R. Rodek acquired 3,693 shares of common stock on 09/01/2025 at a reported price of $0.00, increasing his beneficial ownership to 29,993 shares. The Form 4 indicates the filing was made individually by the reporting person and signed by an attorney-in-fact. No derivative transactions or additional details are reported.

Positive

• Director acquisition disclosed: Jeffrey R. Rodek increased beneficial ownership by 3,693 shares to a total of 29,993 shares.
• Form 4 filed individually and includes an attorney-in-fact signature, indicating regulatory compliance with Section 16 reporting.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchased 3,693 common shares, modestly increasing ownership to 29,993 shares; transaction appears routine and non-cash.

The reported acquisition of 3,693 shares at a $0.00 price suggests a non-cash award or stock grant rather than an open-market purchase. The increase to 29,993 shares is small relative to typical public-company float sizes and is unlikely to materially affect capitalization or market perception. No exerciseable derivatives or dispositions accompany this filing.

Corporate Governance Expert

TL;DR: Insider acquisition by a director signals alignment but is modest; documentation shows Form 4 compliance and attorney-in-fact signature.

The filing demonstrates timely disclosure of a director-level equity change and proper use of an attorney-in-fact for signature. The zero-dollar price and lack of additional notes point to an administrative equity grant or similar corporate issuance. This is a routine governance event with limited investor impact.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider RODEK JEFFREY R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,693	$0.00	--

Holdings After Transaction: Common Stock — 29,993 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RODEK JEFFREY R

(Last) (First) (Middle)

6 LOGUE COURT

(Street)

GREENVILLE SC 29615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2025		A		3,693	A	$0.00	29,993	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	J. Creighton Lynes, attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What change in ownership did SCSC director Jeffrey R. Rodek report?

He reported an acquisition of 3,693 shares of common stock, bringing his beneficial ownership to 29,993 shares.

What was the reported price per share for the transaction on the Form 4?

The transaction is reported at a price of $0.00.

Does the Form 4 report any derivative transactions for SCSC?

No. The filing shows only a non-derivative common stock acquisition and lists no derivative securities.

Who signed the Form 4 for the reporting person?

The signature on the form is by J. Creighton Lynes, acting as attorney-in-fact, dated 09/03/2025.

Was this filing made jointly or by a single reporting person?

The form indicates it was filed by one reporting person.